Answer:
Radium Ra-223 is FDA approved for the treatment of individuals with castration-resistant prostate cancer. For dates of service beginning January 1, 2015, hospital outpatient departments should bill Medicare for Radium Ra-223, using HCPCS code A9606. The revenue code 0636 should also appear on the claim.  In addition to needing the dosage noted on the claim, the provider also needs to indicate that bone metastases are present and that visceral metastases are absent in the Remarks field on the UB-04 or its electronic equivalent.

 

Contact Palmetto GBA JJ Part A Medicare

Provider Contact Center: 877-567-7271

Email JJ Part A

Contact a specific JJ Part A department


Click to Chat Now